Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Chemotherapy for Primary CNS Germ Cell Tumors in Children

This page was last updated on May 9th, 2017

Treatment of Primary CNS Germinomas

  • Biopsy when diagnosis in question: The initial approach is to perform a biopsy +/- CSF diversion procedure only if the diagnosis cannot be made on serum or CSF tumor markers alone.
  • 25% relapse with radiotherapy alone: Traditionally, germinomas were treated with radiation alone as they are exquisitely sensitive to it. Germinomas are also very sensitive to chemotherapy; however, 25% of patients relapse if the chemotherapy is not followed with radiation (57).
  • Pretreatment with chemotherapy reduces radiation dose: Although germinomas can be cured with radiation alone, the current trend is to treat with chemotherapy first with the expectation that a complete response will be induced. This will allow a reduction in the dose of radiation and thus a reduction in the long-term side effects of radiation. Two to four cycles of carboplatin- and etoposide- based therapy are usual for germinomas. In the absence of dissemination at diagnosis, current trends are toward whole ventricular radiation after a complete response to chemotherapy with or without resection (58, 59, 63).
  • Resect residual tumor after chemotherapy: The resection is followed by induction chemotherapy. If the tumor grows or if there is a surgically amenable residual mass with normalization of tumor markers, then resection is considered to remove the likely teratoma component.

SIOP CNS protocol 96 (63)

  • Days 1–3 and 43–45: Carboplatin, 600 mg/m²/day IV; etoposide, 100 mg/m²/day IV
  • Days 22–27 and 64–69: Etoposide, 100 mg/m²/day IV; ifosfamide, 1800 mg/m²/day IV

Treatment of Malignant CNS Germ Cell Tumors

  • Serum and CSF markers diagnostic: Malignant CNS germ cell tumors are diagnosed on the basis of tumor markers in serum and CSF.
  • Combined radiation therapy and chemotherapy: Malignant CNS germ cell tumors are more aggressive and require more intense chemotherapy than germinomas (60). They also are highly responsive to chemotherapy; however, a relapse rate of 70% is observed if chemotherapy is not followed by radiation therapy (57). Radiation therapy alone also has a low cure rate. Radiation therapy is usually 36 Gy craniospinal (62); however, present clinical trials are exploring the possibility of whole ventricular radiation in those with localized disease at diagnosis.
  • Surgery for residual after chemotherapy: Second-look surgery is considered for growing teratoma syndrome (61) or surgically amenable residual disease prior to radiation.

Induction chemotherapy – four 28-day cycles (64)

  • Days 1–5: Cisplatin, 20 mg/m²/day IV
  • Days 1–5: Etoposide, 75 mg/m²/ day IV
  • Days 1–5: Ifosfamide, 1.2 g/ m²/ day IV

Dose intensification chemotherapy for residual disease

Two cycles with each cycle having a duration of 21 days are used if there has not been a complete response to induction chemotherapy. This regimen is coupled with blood stem cell rescue using bone marrow transplantation (64).

  • Days 1–2: Cyclophosphamide, 2 g/m²/day IV
  • Days 1–3: Carboplatin, 400 mg/m²/day IV
  • Bone marrow rescue: Infusion of >2 x 106 CD 34 stem cells 48–72 hours after completion of chemotherapy

Complications

Outcome

  • Germinoma 5-year survival rate near 100%: Localized germinomas treated with multimodality therapy have a 5-year EFS rate of 88% and an OS rate of 96% (63).
  • Malignant germ cell tumor 10-year survival rate 77%: Malignant germ cell tumors treated with multimodality therapy have a 10-year PFS rate of 74% and an OS rate of 77% (62).

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.